EGFR and breast cancer: Another way to inhibit kinases is the use of kinase-targeted antibodies, which has been reported to be effective in various cancers [34], for instance, monoclonal antibody against epidermal growth factor receptor (EGFR) in colorectal cancer [55] and against HER2 in breast cancer [56,57].